| P2093 | author name string | Tomomi Nakamura | |
| | Kiyoko Fukami | |
| | Yumi Murayama | |
| | Reiko Satow | |
| | Tamaki Hirano | |
| | Ryosuke Batori | |
| P2860 | cites work | β-catenin inhibits promyelocytic leukemia protein tumor suppressor function in colorectal cancer cells | Q24299284 |
| | Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of beta-catenin signaling, Slug, and MAPK | Q24672084 |
| | E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components. | Q28972461 |
| | Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways | Q29615855 |
| | Phospholipase C isozymes are deregulated in colorectal cancer--insights gained from gene set enrichment analysis of the transcriptome | Q34016649 |
| | Quality of life analysis in patients with KRAS wild-type metastatic colorectal cancer treated first-line with cetuximab plus irinotecan, fluorouracil and leucovorin | Q34644867 |
| | Activated KrasG¹²D is associated with invasion and metastasis of pancreatic cancer cells through inhibition of E-cadherin. | Q34727214 |
| | Identification of novel small compounds that restore E-cadherin expression and inhibit tumor cell motility and invasiveness. | Q34987214 |
| | BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells: a comparative study | Q35299011 |
| | Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro | Q37459913 |
| | Implications for KRAS status and EGFR-targeted therapies in metastatic CRC. | Q37563971 |
| | Targeted therapy in metastatic colorectal cancer -- an example of personalised medicine in action. | Q38078599 |
| | RAS signaling pathways, mutations and their role in colorectal cancer | Q38116869 |
| | The physiological roles of primary phospholipase C. | Q38138205 |
| | Phosphatidylinositol 5-phosphate 4-kinase type II beta is required for vitamin D receptor-dependent E-cadherin expression in SW480 cells | Q39554360 |
| | E-cadherin inhibits tumor cell growth by suppressing PI3K/Akt signaling via β-catenin-Egr1-mediated PTEN expression. | Q39597035 |
| | Gain of oncogenic function of p53 mutants regulates E-cadherin expression uncoupled from cell invasion in colon cancer cells | Q39724059 |
| | Phospholipase Cdelta1 is required for skin stem cell lineage commitment | Q39777505 |
| | Loss of homotypic cell adhesion by epithelial-mesenchymal transition or mutation limits sensitivity to epidermal growth factor receptor inhibition | Q40169788 |
| | Dual activation of phospholipase C-epsilon by Rho and Ras GTPases | Q42111341 |
| | Epidermal phospholipase Cδ1 regulates granulocyte counts and systemic interleukin-17 levels in mice | Q42832660 |
| | Down-regulation of MEK/ERK signaling by E-cadherin-dependent PI3K/Akt pathway in differentiating intestinal epithelial cells | Q44773184 |
| | Oncogenic K-ras drives cell cycle progression and phenotypic conversion of primary pancreatic duct epithelial cells | Q45020384 |
| | Phospholipase Cepsilon promotes intestinal tumorigenesis of Apc(Min/+) mice through augmentation of inflammation and angiogenesis. | Q46003371 |
| | Regulation of Wnt signaling by the nuclear pore complex | Q46624298 |
| | Phospholipase C epsilon plays a suppressive role in incidence of colorectal cancer. | Q54365151 |
| | Prognostic significance of the wnt signalling pathway molecules APC, beta-catenin and E-cadherin in colorectal cancer: a tissue microarray-based analysis. | Q54442810 |
| | Extracellular calcium and calcium sensing receptor function in human colon carcinomas: promotion of E-cadherin expression and suppression of beta-catenin/TCF activation. | Q54796398 |
| | Genetic pathways in colorectal and other cancers | Q57337198 |
| | Prognostic significance of E-cadherin expression in human colorectal cancer tissue | Q73719746 |
| | Loss of E-cadherin promotes the growth, invasion and drug resistance of colorectal cancer cells and is associated with liver metastasis | Q83396650 |
| P433 | issue | 37 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colorectal cancer | Q188874 |
| | colorectal carcinoma | Q25493920 |
| P304 | page(s) | 13505-13510 | |
| P577 | publication date | 2014-09-02 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Phospholipase Cδ1 induces E-cadherin expression and suppresses malignancy in colorectal cancer cells | |
| P478 | volume | 111 | |